Scientists say study findings indicate that TC IV cells may represent a therapeutic target for the treatment of ...

US FDA approves Bio-Thera Solutions & Hikma Pharma’s Starjemza injection, a biosimilar referencing Stelara injection: Guangzhou Wednesday, May 28, 2025, 17:00 Hrs [IST] Bio-Ther ...

Q1 2025 Earnings Call Transcript May 12, 2025 Coherus BioSciences, Inc. misses on earnings expectations. Reported EPS is $-0.35 EPS, expectations were $-0.31. Operator: Good day and thank you for ...

How CD4+ T cells respond to Chikungunya virus may trigger long-lasting joint pain, mimicking autoimmune disease long after ...

The following is a summary of “Expansion of multiple CD4+ T cell lineages in lymphocytic variant hypereosinophilic syndrome,” ...

Chimeric antigen receptor (CAR) T cells targeting CD19 have transformed the treatment of B-cell cancers, but many patients do not have long-term remission. We designed an anti-CD19 enhanced ...

CD4 T-Cell Monitoring in HIV Management Key Themes: Immune Reconstitution: Average CD4 count increases of approximately 200 cells in the first year of effective therapy Laboratory Variability: CD4 ...